1. Home
  2. Live Updates
  3. ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட்

Page 6 - ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் Today - Breaking & Trending Today

China approves another inactivated Covid vax for emergency use


China approves another inactivated Covid vax for emergency use
​ By
IANS
|
​ 3 Views
beijing : China s Anti-Corona Vaccine Helps International Fight Against Epidemic. Image Source: IANS News
Beijing, May 15 : China has approved one more inactivated Covid-19 vaccine for emergency use, according to an announcement by the developer of the jab.
Shenzhen Kangtai Biological Products Co., Ltd., the developer, said on Friday that the vaccine it developed has started related work for Phase III clinical trial, reports Xinhua news agency.
The vaccine reported no adverse events with an intensity of grade 3 or above in the first two phases of its clinical trials, according to the company s research submitted to MedRxiv, a web portal distributing preprints about health sciences. ....

World Health Organization , Shenzhen Kangtai Biological Products Co Ltd , Common Terminology Criteria , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் , பொதுவானது சொல் அளவுகோல்கள் ,

Private Company Says MOH Has Approved Its Phase 3 Clinical Trial Of COVID-19 Vaccine


news
Private Company Says MOH Has Approved Its Phase 3 Clinical Trial Of COVID-19 Vaccine
The company, which deals in tourism and property, stated that this will help Malaysia attract huge investment as well as create job opportunities in the pharmaceutical sector.
By Sadho Ram
— 28 Apr 2021, 06:07 PM
Subscribe to our Telegram channel for our latest stories and breaking news.
A property developer has obtained the Ministry of Health s approval for its Phase 3 clinical trial study of inactivated COVID-19 trial vaccines in Malaysia, as per its announcement on Bursa Malaysia
With the approval, the property developer Yong Tai Berhad — under its healthcare subsidiary YTB Healthcare Sdn Bhd (YTBH) — has become the first private company to initiate and sponsor the Phase 3 clinical trial of the COVID-19 vaccines in Malaysia. ....

Yong Tai , Sdn Bhd , Yong Tai Berhad , Shenzhen Kangtai Biological Products Co Ltd , Ethics Committee , Ministry Of Health , National Pharmaceutical Regulatory Authority , Medical Review , Bursa Malaysia , Datuk Wira Boo Kuang Loon , Edge Malaysia , Private Sector , Covid 19 , யோங் தை , ஸ்டன் ப்ட் , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் , நெறிமுறைகள் குழு , அமைச்சகம் ஆஃப் ஆரோக்கியம் , தேசிய மருந்து ஒழுங்குமுறை அதிகாரம் , மருத்துவ விமர்சனம் , விளிம்பு மலேசியா , ப்ரைவேட் துறை , தடுப்பு மருந்துகள் ,

Yong Tai says ministry has approved its Phase III clinical trial of Covid-19 vaccine


KUALA LUMPUR (April 26): Property developer Yong Tai Bhd said its healthcare subsidiary has obtained approval from the Ministry of Health s Medical Review & Ethics Committee (MREC) for its Phase III clinical trial study of inactivated Covid-19 trial vaccines in Malaysia.
The board wishes to announce that MREC had vide its letter dated April 23, approved the said Phase III Clinical Trial study to be carried out in Malaysia involving 3,000 subjects, the group said in a bourse filing today.
The health ministry has not made a statement on this matter so far.
Yong Tai said its unit, YTB Healthcare Sdn Bhds (YTBH), has formalised the Phase III clinical trial with its partner, Shenzhen Kangtai Biological Products Co Ltd (SZKT), since December last year. SZKT is a vaccine manufacturer in China. ....

Kuala Lumpur , Yong Tai , Sdn Bhds , Yong Tai Bhd , Shenzhen Kangtai Biological Products Co Ltd , Ministry Of Health Medical Review Ethics Committee , National Pharmaceutical Regulatory Authority , Medical Review , Ethics Committee , Datuk Wira Boo Kuang Loon , குவாலா லம்பூர் , யோங் தை , யோங் தை ப்ட் , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் , தேசிய மருந்து ஒழுங்குமுறை அதிகாரம் , மருத்துவ விமர்சனம் , நெறிமுறைகள் குழு ,

M'sia, China working together in procurement deals, clinical trials for other Chinese vaccines, says China envoy

M'sia, China working together in procurement deals, clinical trials for other Chinese vaccines, says China envoy
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.

Wang Zhigang , Malaysia General , Ouyang Yujing , Khairy Jamaluddin , Yong Tai Bhd , Sinovac Coronavac , Wang Yi , Malaysia Health Ministry , Kl International Airport , China Shenzhen Kangtai Biological Products Co Ltd , Sinovac Life Sciences Co Ltd , Malaysia Ouyang , Health Ministry , Shenzhen Kangtai Biological Products Co Ltd , Medical Biology Chinese Academy , Medical Sciences , President Xi Jinping , State Councillor , மலேசியா ஜநரல் , கைரி ஜமாலுதீன் , யோங் தை ப்ட் , வாங் இ , மலேசியா ஆரோக்கியம் அமைச்சகம் , க்ல் சர்வதேச விமான , சீனா ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் , ஆரோக்கியம் அமைச்சகம் ,

Global Pneumonia Vaccine Market 2021 Global Trend, Segmentation and Opportunities Forecast To 2025


Global Pneumonia Vaccine Market 2021 Global Trend, Segmentation and Opportunities Forecast To 2025
The forecast involves key details on market size, market share, statistics, application, and revenue.
BriefingWire.com, 2/20/2021 -
Facto Market Insights recently published market research study on the Global Pneumonia Vaccine Market (2021-2025) to its own collection of research reports. The study report covers detailed analysis of market sizing and forecasting of the market covering the market drivers, challenges, opportunity analysis, and tendencies, together with assorted important insights in the worldwide industry. The study report also contains the investigation of regional producers and brand new market players, covering all of the information acceptable for its customers to produce strategic business decisions in the business. ....

United States , United Kingdom , South Africa , New Zealand , South Korea , Mark Johnson , Asia Pacific , Pneumonia Vaccine Market Company Analysis , Industry Development , Company Market Share Positioning , Porter Five Forces Analysis Trade , Merck Co Inc , Lg Chem Ltd , Panacea Biotec , Serum Institute Of India Pvt , Pfizer Inc , Minhai Biotechnology Corporation , Pnuvax Incorporated , Distribution Partner Companies , Shenzhen Kangtai Biological Products Co Ltd , Pneumonia Vaccine Market , Market Insights , Global Pneumonia Vaccine Market , Sample Copy , More Information , Please Visit ,